Handelsbanken Fonder AB Has $6.65 Million Holdings in Astera Labs, Inc. $ALAB

Handelsbanken Fonder AB cut its stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 68.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 40,000 shares of the company’s stock after selling 86,200 shares during the quarter. Handelsbanken Fonder AB’s holdings in Astera Labs were worth $6,654,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Perigon Wealth Management LLC raised its holdings in shares of Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after buying an additional 73 shares in the last quarter. Clearstead Advisors LLC increased its holdings in Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after purchasing an additional 76 shares in the last quarter. Sound Income Strategies LLC increased its holdings in Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock valued at $164,000 after purchasing an additional 76 shares in the last quarter. Venturi Wealth Management LLC increased its holdings in Astera Labs by 2.6% during the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares in the last quarter. Finally, Great Valley Advisor Group Inc. increased its holdings in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after purchasing an additional 90 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Astera Labs

In other news, COO Sanjay Gajendra sold 280,000 shares of the firm’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total value of $69,773,200.00. Following the transaction, the chief operating officer directly owned 615,000 shares in the company, valued at $153,251,850. This trade represents a 31.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the firm’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,915,461 shares of company stock worth $358,508,976 in the last three months. Insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $306.88 on Friday. The firm has a market capitalization of $52.60 billion, a price-to-earnings ratio of 207.35, a PEG ratio of 3.94 and a beta of 3.35. The business’s fifty day moving average price is $170.39 and its two-hundred day moving average price is $159.79. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $315.81.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ALAB shares. UBS Group started coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target for the company. Susquehanna raised their price target on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Royal Bank Of Canada raised their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Citigroup raised their price target on Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. raised their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Get Our Latest Stock Analysis on Astera Labs

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
  • Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
  • Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
  • Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.